CAR-T Cell Therapy Success for Treatment-Resistant Follicular Lymphoma
A specialized €300,000 CAR-T cell therapy is actively being deployed at the CHU de Nantes for patients battling aggressive, refractory blood cancers such as follicular lymphoma. This advanced immunotherapy reprograms … Read More